A Study to Determine the Effect of Multiple Oral Doses of SLx-2119 in Healthy Male Subjects

Clinical trial NCT05918627 · COMPLETED

Trial details

NCT number: NCT05918627
Sponsor: Kadmon, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Immune System Disorder (Healthy Volunteer)

Start date: 2009-09-21
Primary completion: 2009-12-09
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.